Richmond Pharmacology is excited to join DIA Europe 2026 in Rotterdam, The Netherlands, on 24–26 March 2026.

Uniting global leaders from across the life sciences ecosystem, DIA Europe serves as a major forum for advancing regulatory science, clinical development, real‑world evidence, and patient‑centred innovation through cross‑sector collaboration.

Representing Richmond Pharmacology:

  • Elizabeth Romano, Director of Communications and Participant Engagement

Our Focus at the Conference

  • Regulatory innovation and evolving compliance frameworks
  • Future‑ready clinical trial methodologies
  • Real‑world evidence and data‑driven decision‑making
  • Patient‑centred approaches to development
  • Strengthening partnerships across the life sciences ecosystem

Connect With Us

If you are attending DIA Europe 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: DIA - DIA Europe 2026

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event